Each vegetable capsule contains:
Hibiscus sabdariffa flower extract,
15% anthocyanidins 600 mg
Contains no: Preservatives, artificial flavor or color, sugar, dairy, starch, wheat, gluten, yeast, soy, citrus, or eggs.
Hibiscus sabdariffa (hibiscus) is a medicinal botanical that maintains cardiovascular health, based on evidence from several clinical trials. Hibiscus has a beneficial effect on blood pressure, blood sugar, and cholesterol, and has antioxidant properties. This botanical has been used historically in both Asia and Africa as an aqueous extract or tea to treat high blood pressure, liver disease, and fevers. Hibiscus possesses several active constituents, including anthocyanidins which are thought to be the source of its antioxidant effects.
1 capsule one to three times daily or as directed by your health care practitioner.
Consult a health care practitioner prior to use if you are pregnant or breast-feeding. Hypersensitivity has been known to occur ; in which case, discontinue use.
1. Hopkins, A.L., et al. “Hisibcus sabdariffa L. in the treatment of hypertension and hyperlipidemia: A comprehensive review of animal and human studies”. Fitoterapia Vol. 85 (2013): 84–94.
2. Saunders, L. and P. Rouchotas. “Hibiscus — An emerging new botanical medicine”. IHP magazine (2013): 67–71.
3. Ojeda, D., et al. “Inhibition of angiotensin converting enzyme (ACE) activity by the anthocyanins delphinidin- and
cyaniding-3-O-sambubiosides from Hibiscus sabdariffa”. Journal of Ethnopharmacology Vol. 127, No. 1 (2010): 7–10.
4. Frank, T., et al. “Pharmacokinetics of anthocyanidin-3-glycosides following consumption of Hibiscus sabdariffa L.
extract”. Journal of Clinical Pharmacology Vol. 45, No. 2 (2005): 203–210.
5. Herrera-Arellano, A., et al. “Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa
on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial”. Planta Medica Vol. 73,
No. 1 (2007): 6–12.
6. Herrera-Arellano, A., et al. “Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients
with mild to moderate hypertension: a controlled and randomized clinical trial”. Phytomedicine Vol. 11, No. 5 (2004):
7. Yang, M.Y., et al. “The hypolipidemic effect of Hibiscus sabdariffa polyphenols via inhibiting lipogenesis and promoting
hepatic lipid clearance”. Journal of Agricultural and Food Chemistry Vol. 58, No. 2 (2010): 850–859.
8. Kuriyan, R., et al. “An evaluation of the hypolipidemic effect of an extract of Hibiscus sabdariffa leaves in hyperlipidemic Indians: a double blind, placebo controlled trial”. BMC Complementary and Alternative Medicine Vol. 10 (2010): 27–34. 9. Gurrola-Diaz, C.M., et al. “Effects of Hibiscus sabdariffa extract powder and prevention treatment (diet) on the lipid
profiles of patients with metabolic syndrome (MeSy)”. Phytomedicine Vol. 17, No. 7 (2010): 500–505.
10. Kao, E.S., et al. “Anthocyanin extracted from Hibiscus attenuate oxidized LDL-mediated foam cell formation involving
regulation of CD36 gene”. Chemico-Biological Interactions Vol. 179, No. 2–3 (2009): 212–218.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.